Cited by 101Viral-associated cancers and disordersCervical Cancer and HPV ResearchHepatitis B Virus Studies

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Vaccines to Prevent Infections by Oncoviruses

Open access

Schiller, John T., Lowy, Douglas R.·2010·Annual Review of Microbiology

DOI 10.1146/annurev.micro.112408.134019PMC PMC6264788

Open this paper in CoChat — free account

Abstract

It has been estimated that viruses are etiological agents in approximately 12% of human cancers. Most of these cancers can be attributed to infections by human papillomavirus (HPV), hepatitis B virus (HBV), hepatitis C virus (HCV), Epstein-Barr virus (EBV), and Kaposi's sarcoma–associated herpesvirus (KSHV). Prophylactic vaccines against other pathogenic viruses have an excellent record as public health interventions in terms of safety, effectiveness, and ability to reach economically disadvantaged populations. These considerations should prompt efforts to develop and implement vaccines against oncoviruses. Safe and effective HBV and HPV vaccines, based on virus-like particles, are commercially available, and the major focus is now on vaccine delivery, especially to low-resource settings. HCV and EBV vaccines are under active development, but few clinical trials have been conducted, and none of the candidate vaccines has proven to be sufficiently effective to warrant commercialization. Efforts to develop KSHV vaccines have been more limited.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1146/annurev.micro.112408.134019

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant
Urisman, A., Molinaro, R. J., Fischer, N., Plummer, S. J., Casey, G., Klein, E. A., Malathi, K., Magi-Galluzzi, C., Tubbs, R. R., Ganem, D., et al. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020025 · Cited by 577
Retracted
Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma
Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., & Moore, P. S. (1994) · Science · doi:10.1126/science.7997879 · Cited by 5,608
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043 · cited 1×
“Human T cell leukemia virus type 1 (HTLV1) was first identified in 1980 from a patient with cutaneous T cell leukemia (66).”
Background
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A. T., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,587
Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma
Feng, H., Shuda, M., Chang, Y., & Moore, P. S. (2008) · Science · doi:10.1126/science.1152586 · Cited by 3,208
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C., Hwang, L., & Chien, C. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,856
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
Epstein, M. A., Achong, B. G., & Barr, Y. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91524-7 · Cited by 2,793
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.
Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S., & Miyoshi, I. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6476 · Cited by 2,252

Show all 85 references

Research works printed but not linked: 7

Hino S, 1997, Leukemia, 11, 57
37. Howley PM, Lowy DR. 2007. Pappillomaviruses. See Ref. 48, pp. 2299–354
Knipe DM, 2007, Field's Virology
51. Latirmore MD, Franchini G. 2007. Human T-cell leukemia types 1 and 2. See Ref. 48, pp. 2071–105
Mast EE, 2004, Vaccines, 205
68. Richardson AB, Kieff E. 2007. Epstein-Barr virus. See Ref. 48, pp. 2655–700
Westmoreland SV, 2008, Comp. Med., 58, 31

Sorted by citations

Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,975
Human Viral Oncogenesis: A Cancer Hallmarks Analysis
Mesri, E. A., Feitelson, M. A., & Münger, K. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.011 · Cited by 672
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
Llovet, J. M., Pinyol, R., Yarchoan, M., Singal, A. G., Marron, T. U., Schwartz, M., Pikarsky, E., Kudo, M., & Finn, R. S. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00868-0 · Cited by 391
T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance
Chandran, S. S., & Klebanoff, C. A. (2019) · Immunological Reviews · doi:10.1111/imr.12772 · Cited by 337
The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches
Pandya, P. H., Murray, M. E., Pollok, K. E., & Renbarger, J. L. (2016) · Journal of Immunology Research · doi:10.1155/2016/4273943 · Cited by 270
Future directions in cancer prevention
Umar, A., Dunn, B. K., & Greenwald, P. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3397 · Cited by 253
Reducing HPV-Associated Cancer Globally
Lowy, D. R., & Schiller, J. T. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0542 · Cited by 239
Self-citation
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T‐cell activation
Rosalia, R. A., Quakkelaar, E. D., Redeker, A., Khan, S., Camps, M. G. M., Drijfhout, J. W., Silva, A. L., Jiskoot, W., van Hall, T., van Veelen, P. A., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201343324 · Cited by 217
Enhancing in situ cancer vaccines using delivery technologies
Gong, N., Alameh, M., El-Mayta, R. D., Xue, L., Weissman, D., & Mitchell, M. J. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00974-9 · Cited by 197
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
Klebanoff, C. A., Chandran, S. S., Baker, B. M., Quezada, S. A., & Ribas, A. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00809-z · Cited by 164
Immune modulation during latent herpesvirus infection
White, D. W., Beard, R. S., & Barton, E. S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01074.x · Cited by 155
An Introduction to Virus Infections and Human Cancer
Schiller, J. T., & Lowy, D. R. (2020) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-030-57362-1_1 · Cited by 150
Self-citation
Immunotherapy against cancer-related viruses
Tashiro, H., & Brenner, M. K. (2016) · Cell Research · doi:10.1038/cr.2016.153 · Cited by 147
The gut microbiota in cancer immunity and immunotherapy
Xie, M., Li, X., Lau, H. C.-H., & Yu, J. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01326-2 · Cited by 132
Kaposi's Sarcoma Herpesvirus MicroRNAs Induce Metabolic Transformation of Infected Cells
Yogev, O., Lagos, D., Enver, T., & Boshoff, C. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004400 · Cited by 121
Mechanisms linking pathogens-associated inflammation and cancer
Porta, C., Riboldi, E., & Sica, A. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.10.012 · Cited by 119
Neutralization Serotyping of BK Polyomavirus Infection in Kidney Transplant Recipients
Pastrana, D. V., Brennan, D. C., Çuburu, N., Storch, G. A., Viscidi, R. P., Randhawa, P. S., & Buck, C. B. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002650 · Cited by 109
The prevention of infection-associated cancers
Flora, S. D., & Bonanni, P. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr054 · Cited by 98
Virus Infection and Human Cancer: An Overview
Schiller, J. T., & Lowy, D. R. (2013) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-38965-8_1 · Cited by 92
Self-citation
Topical immunization strategies
Czerkinsky, C. C., & Holmgren, J. R. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.55 · Cited by 88
Colorectal cancer prevention: Immune modulation taking the stage
Fletcher, R., Wang, Y., Schoen, R. E., Finn, O. J., Yu, J., & Zhang, L. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.12.002 · Cited by 82
Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
Tornesello, A. L., Tagliamonte, M., Buonaguro, F. M., Tornesello, M. L., & Buonaguro, L. (2022) · Vaccines · doi:10.3390/vaccines10020227 · Cited by 76
A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice
Ogembo, J. G., Muraswki, M. R., McGinnes, L. W., Parcharidou, A., Sutiwisesak, R., Tison, T., Avendano, J., Agnani, D., Finberg, R. W., Morrison, T. G., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0415-2 · Cited by 76
High-Throughput Pseudovirion-Based Neutralization Assay for Analysis of Natural and Vaccine-Induced Antibodies against Human Papillomaviruses
Sehr, P. A., Rubio, I., Seitz, H., Putzker, K., Ribeiro-Müller, L., Pawlita, M., & Müller, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075677 · Cited by 74
Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches
Mahdevar, E., Safavi, A., Abiri, A., Kefayat, A., Hejazi, S. H., Miresmaeili, S. M., & Mobarakeh, V. I. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1883111 · Cited by 69
Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera
Draper, E., Bissett, S. L., Howell‐Jones, R., Edwards, D., Munslow, G., Soldan, K., & Beddows, S. A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.021 · Cited by 59
Multiple Infections and Cancer: Implications in Epidemiology
Vedham, V., Divi, R. L., Starks, V. L., & Verma, M. (2013) · Technology in Cancer Research & Treatment · doi:10.7785/tcrt.2012.500366 · Cited by 56
Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice
Perez, E. M., Foley, J., Tison, T., Silva, R., & Ogembo, J. G. (2016) · Oncotarget · doi:10.18632/oncotarget.13770 · Cited by 58
Breaking Bottlenecks for the TCR Therapy of Cancer
Gaissmaier, L., Elshiaty, M., & Christopoulos, P. (2020) · Cells · doi:10.3390/cells9092095 · Cited by 52
Interplay between viruses and bacterial microbiota in cancer development
Vyshenska, D., Lam, K. C., Shulzhenko, N., & Morgun, A. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.05.003 · Cited by 49
Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy
Mohite, P. B., Yadav, V., Pandhare, R., Maitra, S., Saleh, F. M., Saleem, R. M., Al-malky, H. S., Kumarasamy, V., Subramaniyan, V., Abdel‐Daim, M. M., et al. (2024) · ACS Omega · doi:10.1021/acsomega.3c06501 · Cited by 47
Prophylactic and therapeutic vaccine development: advancements and challenges
Weerarathna, I. N., Doelakeh, E. S., Kiwanuka, L., Kumar, P., & Arora, S. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00222-x · Cited by 47
Systemic and Mucosal Immune Responses to Sublingual or Intramuscular Human Papilloma Virus Antigens in Healthy Female Volunteers
Huo, Z., Bissett, S. L., Giemza, R., Beddows, S. A., Oeser, C., & Lewis, D. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033736 · Cited by 43
Role of Viral Infections in Testicular Cancer Etiology: Evidence From a Systematic Review and Meta-Analysis
Garolla, A., Vitagliano, A., Muscianisi, F., Valente, U., Ghezzi, M., Andrisani, A., Ambrosini, G., & Foresta, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00355 · Cited by 43
Recent Advances in Cancer Immunotherapy with a Focus on FDA-Approved Vaccines and Neoantigen-Based Vaccines
Hargrave, A., Mustafa, A. S., Hanif, A., Tunio, J. H., & Hanif, S. N. M. (2023) · Vaccines · doi:10.3390/vaccines11111633 · Cited by 38
Anti-cancer vaccines - a one-hit wonder?
Liu, J. K. H. (2014) · Europe PMC (PubMed Central) · Cited by 38
Stress Responses of Bacterial Cells as Mechanism of Development of Antibiotic Tolerance (Review)
Ткаченко, А. Г. (2018) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683818020114 · Cited by 39
Experience with Synthetic Vaccines for Cancer and Persistent Virus Infections in Nonhuman Primates and Patients
Quakkelaar, E. D., & Melief, C. J. M. (2012) · Advances in immunology · doi:10.1016/b978-0-12-396548-6.00004-4 · Cited by 41
Antiviral Activity of Fnc, 2′-Deoxy-2′-β-Fluoro-4′-Azidocytidine, against Human and Duck HBV Replication
Zheng, L., Wang, Q., Yang, X., Guo, X., Chen, L., Tao, L., Dong, L., Li, Y., An, H., Yu, X., et al. (2012) · Antiviral Therapy · doi:10.3851/imp2094 · Cited by 37
DNAzymes, Novel Therapeutic Agents in Cancer Therapy: A Review of Concepts to Applications
Thomas, I. B. K., Gaminda, K. A. P., Jayasinghe, C. D., Abeysinghe, T., & Senthilnithy, R. (2021) · Journal of Nucleic Acids · doi:10.1155/2021/9365081 · Cited by 35
Immunizing against Anogenital Cancer: HPV Vaccines
Pogoda, C. S., Roden, R. B. S., & Garcea, R. L. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005587 · Cited by 33
Sensitive Detection of Viral Transcripts in Human Tumor Transcriptomes
Schelhorn, S.-E., Fischer, M., Toloşi, L., Altmüller, J., Nürnberg, P., Pfister, H., Lengauer, T., & Berthold, F. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003228 · Cited by 34
Current and Potential Treatments for Ubiquitous but Neglected Herpesvirus Infections
Gable, J. E., Acker, T. M., & Craik, C. S. (2014) · Chemical Reviews · doi:10.1021/cr500255e · Cited by 29
Influence of Oxidation and Multimerization on the Immunogenicity of a Thioredoxin-L2 Prophylactic Papillomavirus Vaccine
Seitz, H., Dantheny, T., Burkart, F., Ottonello, S., & Müller, M. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00195-13 · Cited by 28
Vaccination against sexually transmitted infections
Fairley, C. K., & Read, T. R. H. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32834e9aeb · Cited by 28
Emerging topics in human tumor virology
Hoppe‐Seyler, F., & Hoppe‐Seyler, K. (2011) · International Journal of Cancer · doi:10.1002/ijc.26087 · Cited by 25
Ecological and Evolutionary Consequences of Anticancer Adaptations
Boutry, J., Dujon, A. M., Gérard, A., Tissot, S., MacDonald, N., Schultz, A. G., Biro, P. A., Beckmann, C., Hamede, R., Hamilton, D. G., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101716 · Cited by 28
Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2
Seitz, H., Schmitt, M., Böhmer, G., Kopp‐Schneider, A., & Müller, M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27831 · Cited by 24
Advances in therapeutic cancer vaccines: Harnessing immune adjuvants for enhanced efficacy and future perspectives
Ren, D., Xiong, S., Ren, Y., Yang, X., Zhao, X., Jin, J., Xu, M., Liang, T., Guo, L., & Weng, L. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.04.054 · Cited by 23
Antiviral Activity of Various 1-(2′-Deoxy-β- d -lyxofuranosyl), 1-(2′-Fluoro-β- d -xylofuranosyl), 1-(3′-Fluoro-β- d -arabinofuranosyl), and 2′-Fluoro-2′,3′-didehydro-2′,3′-dideoxyribose Pyrimidine Nucleoside Analogues against Duck Hepatitis B Virus (DHBV) and Human Hepatitis B Virus (HBV) Replication
Srivastav, N. C., Shakya, N., Mak, M., Agrawal, B., Tyrrell, D. L., & Kumar, R. K. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100803c · Cited by 23
Viral Infections: Negative Regulators of Apoptosis and Oncogenic Factors
Zamaraev, A. V., Zhivotovsky, B., & Kopeina, G. S. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920100077 · Cited by 22
Human Papillomavirus Antibody Reference Reagents for Use in Postvaccination Surveillance Serology
Bissett, S. L., Wilkinson, D. E., Tettmar, K. I., Jones, N., Stanford, E., Panicker, G., Faust, H., Borrow, R., Soldan, K., Unger, E. R., et al. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05641-11 · Cited by 20
Cancer Prevention: Lessons Learned and Future Directions
Dunn, B. K., & Kramer, B. S. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.11.003 · Cited by 21
Boosting Antitumor Immunity with an Expanded Neoepitope Landscape
Nagel, R., Pataskar, A., Champagne, J., & Agami, R. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1525 · Cited by 21
Tumour Immunotherapy and Applications of Immunological Products: A Review of Literature
Oli, A. N., Adejumo, S. A., Rowaiye, A. B., Ogidigo, J. O., Hampton‐Marcell, J., & Ibeanu, G. C. (2024) · Journal of Immunology Research · doi:10.1155/2024/8481761 · Cited by 17
Polymeric Display of Proteins through High Affinity Leucine Zipper Peptide Adaptors
Craig, P. O., Alzogaray, V., & Goldbaum, F. A. (2012) · Biomacromolecules · doi:10.1021/bm201875p · Cited by 16
E6AP goes viral: the role of E6AP in viral- and non-viral-related cancers
Bandilovska, I., Keam, S. P., Gamell, C., Machicado, C., Haupt, S., & Haupt, Y. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz072 · Cited by 17
Baculovirus expression systems for production of recombinant proteins in insect and mammalian cells
Beljelarskaya, S. N. (2011) · Molecular Biology · doi:10.1134/s002689331101002x · Cited by 16
Viral infections and human cancers: the legacy of Denis Burkitt
Harford, J. B. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.09017.x · Cited by 14
Prevention and Treatment for Epstein–Barr Virus Infection and Related Cancers
Smets, F. N., & Sokal, E. M. (2013) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-38965-8_10 · Cited by 14
The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses
Gilani, U. S., Shaukat, M., Rasheed, A., Shahid, M., Tasneem, F., Arshad, M. I., Rashid, N., & Shahzad, N. (2018) · Journal of Medical Virology · doi:10.1002/jmv.25292 · Cited by 13
Beyond Viral Infections: The Multifaceted Roles of Human Papillomavirus and Epstein-Barr Virus in Shaping the Tumor Microenvironment
Fernandes, Q., Sher, G., Prabhu, K. S., Kuttikrishnan, S., Merhi, M., Dermime, S., Junejo, K., Bhat, A. A., & Shahab Uddin, M. S. (2024) · Discovery Medicine · doi:10.24976/discov.med.202436180.1 · Cited by 12
Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8+ T cell immunity
Bot, A. I., Qiu, Z., Wong, R. M. H., Obrocea, M., & Smith, K. A. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-132 · Cited by 12
Can HPV vaccination help to prevent anal cancer?
Palefsky, J. M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70226-7 · Cited by 12
The new sexual politics of cancer: Oncoviruses, disease prevention, and sexual health promotion
Mamo, L., & Epstein, S. (2016) · BioSocieties · doi:10.1057/biosoc.2016.10 · Cited by 11
Avian Models for Human Carcinogenesis—Recent Findings from Molecular and Clinical Research
Niebora, J., Data, K., Domagała, D., Józkowiak, M., Barrett, S., Abbariki, T. N., Bryja, A., Kulus, M., Woźniak, S., Ziemak, H., et al. (2024) · Cells · doi:10.3390/cells13211797 · Cited by 9
Mining for viral fragments in methylation enriched sequencing data
Mensaert, K., Criekinge, W. V., Thas, O., Schuuring, E. M. D., Steenbergen, R. D. M., Wisman, G. B. A., & Meyer, T. D. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00016 · Cited by 8
Immune Control and Vaccination against the Epstein–Barr Virus in Humanized Mice
Münz, C. (2019) · Vaccines · doi:10.3390/vaccines7040217 · Cited by 8
Unveiling the nexus: The tumor microenvironment as a strategic frontier in viral cancers
Fernandes, Q., & Folorunsho, O. G. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156827 · Cited by 7
The Immunogenic Potential of Recurrent Cancer Drug Resistance Mutations: An In Silico Study
Punta, M., Jennings, V. A., Melcher, A. A., & Lise, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.524968 · Cited by 7
Oncogenic Viruses in Skull Base Chordomas
Yakkioui, Y., Speel, E. M., van Overbeeke, J. J., Boderie, M., Pujari, S., Hausen, A. Z., Wolffs, P. F. G., & Temel, Y. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.11.117 · Cited by 6
Recent advancements in the cancer vaccines: A review
Kawish, S. M., Hilles, A. R., Sharma, S., Alam, M., Alimujiang, K., Iqbal, Z., Beg, S., Mahmood, S., & Mirza, M. A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106422 · Cited by 3
Emerging Trends in Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: A Focus on Liver Transplant Candidates
Yu, D., Chen, H., & Wang, L. (2025) · Cancer Reports · doi:10.1002/cnr2.70244 · Cited by 2
Future directions and progress in cancer genetics
Khan, I. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33302-6.00008-1 · Cited by 2
The Immunomodulatory Roles of Extracellular Vesicles in the Pathogenesis of Virus-Related Cancers
Heidarzadeh-Asl, S., Kashanchi, F., & Jafari, R. (2026) · Viral Immunology · doi:10.1177/08828245251413728 · Cited by 1
Prevention and Early Detection of Cancer - A Public Health View
Majnarić, L. T., & Včev, A. (2012) · InTech eBooks · doi:10.5772/48042 · Cited by 1
Cancer Prevention II: Introduction
Dunn, B. K., & Greenwald, P. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.06.016 · Cited by 1
Therapeutic Approaches to Employ Monoclonal Antibody for Cancer Treatment
Martins, S., Salvi, P., Lavuri, S. T., Srivastava, M., Sakthivel, S., Barman, M. K., Chand, K., Singh, M., Sonkar, S. C., & Bhukya, P. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-6530-8.ch002 · Cited by 1
Immunity to Oncogenic Viruses
Münz, C., & Ploß, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00250-7 · Cited by 1
Chapter 21 – Vaccination to Treat Noninfectious Diseases: Surveying the Opportunities
Bachmann, M. F., & Vogel, M. (2006) · Academic Press eBooks · Cited by 1
Targeting Molecular Pathways for Prevention of High Risk Breast Cancer: A Model for Cancer Prevention
Showalter, S. L., & Brian, J. (2012) · InTech eBooks · doi:10.5772/31700 · Cited by 1
Miscellaneous Approaches and Considerations: TLR Agonists and Other Inflammatory Agents, Anti-Chemokine Agents, Infectious Agents, Tumor Stroma Targeting, Age and Sex Effects, and Miscellaneous Small Molecules
Svatek, R. S., & Curiel, T. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4732-0_13 · Cited by 1
Vaccination Against Breast Cancer and its Role in Prevention
Czerniecki, B. J., Nocera, N. F., Lowenfeld, L., Showalter, L., & Koski, G. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-27135-4_10 · Cited by 1
Hightech in der Infektiologie: Diagnose und Therapie
Bugert, J. J. (2012) · Springer eBooks · doi:10.1007/978-3-642-17158-1_4
Can HPV vaccination help to prevent anal cancer
Stahl, J. ‐., & Mailles, A. (2010)
Oral cancer with special reference to virus detection and quantitative gene expression
Jalouli, M. M. (2016)
Immunity to Oncogenic Viruses
Rickinson, A. B., Easom, N. J. W., Maini, M. K., & Rowe, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.14025-1
Cancer Defenses in Humans and the Search for a Vaccine
Lu, Y. W. (2020) · Novel Approaches in Cancer Study · doi:10.31031/nacs.2020.05.000608
Hepatitis B core (HBc) virus like particle (VLP) as a platform for innovation of chimeric adjuvant-free VLP vaccines targeting oncoviruses
Zhang, B. (2021) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
The role of Human Cytomegalovirus infection in Iraqi brain tumor patients
Amer, E. M., Alkhfaji, A. H. M. A., & .Hamad, Z. N. (2017) · Numerical Methods in Civil Engineering
Vaccination to Treat Noninfectious Diseases
Bachmann, M. F., & Vogel, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804019-5.00021-9
REVIEW
(2012) · Asia-Pacific Biotech News · doi:10.1142/s0219030312000043
From oncolytic virotherapy to individualized multimodal immunotherapy with focus on glioblastoma
Kampers, L. F. C., de Vliet, P. V., Schirrmacher, V., Gool, S. V., & Stücker, W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00020-5
Prospects of a Potential Vaccine for Kaposi’s Sarcoma-Associated Herpes Virus (KSHV)
Mani, M., Eshak, D., Arumugam, M., & Ponnuswamy, N. (2025) · Springer eBooks · doi:10.1007/978-3-031-77911-4_27
Molecular mastery: Harnessing DNA technology for disease prevention
Dornadula, G., Ramakrishna, C., Shaik, S. B., Meriga, P. K., Chintha, L., Gurugari, Y., D., K., Shaik, S. F., & Cheong, S. H. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101976
Role of Oncoviruses in Cancer Progression and Emerging Phytochemical-Based Therapies from Medicinal Plants
Singh, S., & Yadav, P. (2026) · Molecular Biotechnology · doi:10.1007/s12033-026-01561-6
Role of cancer vaccines in cancer immunotherapy
Kottarath, S. K., Singh, J., Pandey, A., & Srivastava, Y. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-41551-7.00009-6
Applications of virus-like particles in therapeutics
Sharma, S., Pathan, H. K., Gupta, P. K., Mishra, M. K., & Sharma, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44119-6.00012-4
Immunological Determinants of Oncogenic Virus-Driven Cancers in Africa: Mechanisms, Co-Infections and Public Health Challenges
Aliyu, V. A., Akinsulie, O. C., Olowu, B. I., Idris, I., Ajibade, F. A., Babawale, P. I., Adebowale, O. O., Ugwu, C. E., Ukauwa, C. B., Itumo, O. E., et al. (2026) · Pathogens · doi:10.3390/pathogens15080800
FAIRsharing record for: Virus Particle Explorer
FAIRsharing Team, & McQuilton, P. (2022) · FAIRsharing.org · doi:10.25504/fairsharing.45e0f5

Authors: Schiller, J. T., & Lowy, D. R.
Affiliations: National Cancer Institute (US)
ORCID: Schiller, John T.
Lowy, Douglas R.
Venue: Annual Review of Microbiology
Publisher: Annual Reviews
Published: 2010-10-13
Volume: 64
Issue: 1
Pages: 23-41
ISSN: 0066-4227 (ISSN-L)
1545-3251
DOI: 10.1146/annurev.micro.112408.134019
PMC: PMC6264788
OpenAlex: W2118603752
Cited by: 101
References: 85
Citations by year: 2026: 6 · 2025: 6 · 2024: 11 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 7 · 2019: 4 · 2018: 3 · 2017: 5 · 2016: 9 · 2015: 2 · 2014: 4 · 2013: 9 · 2012: 15
FWCI: 1.29
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Annual Review of Microbiology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Cancer Institute (ZIABC010579)
Topics: Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
Keywords: viral etiology of cancer, human papillomavirus, hepatitis B virus, hepatitis C virus, Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, virus-like particle vaccine, vaccine delivery, resource-limited settings, vaccine safety and effectiveness
MeSH terms: Herpesvirus 4, Human, Hepatitis B, Hepatitis B virus, Hepatitis C, Herpesviridae Infections, Humans, Neoplasms, Retroviridae, Viral Vaccines, Hepacivirus, Herpesvirus 8, Human, Epstein-Barr Virus Infections, Papillomaviridae, Papillomavirus Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vaccines to Prevent Infections by Oncoviruses

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks